The repulsive guidance molecule (RGM) is a membrane-bound protein that has diverse functions in the developing central nervous system. Identification of neogenin as a receptor for RGM provided evidence of its cell death-inducing activity in the absence of RGM. Here, we show that the serine/threonine kinase death-associated protein kinase (DAPK) is involved in the signal transduction of neogenin. Neogenin interacts with DAPK and reduces DAPK autophosphorylation on Ser308 in vitro. Neogenininduced cell death is abolished in the presence of RGM or by blocking DAPK. Although neogenin overexpression or RGM downregulation in the chick neural tube in vivo induces apoptosis, coexpression of the dominant-negative mutant or smallinterference RNA of DAPK attenuates this proapoptotic activity. Thus, RGM/neogenin regulates cell fate by controlling the DAPK activity. Cell Death and Differentiation (2008) 15, 1593-1608 doi:10.1038/cdd.2008; published online 27 June 2008
The repulsive guidance molecule (RGM) is a glycosylphosphatidylinositol -anchored glycoprotein that does not share significant homology with any other proteins. RGM was originally identified as a membrane-bound protein having repulsive and growth cone collapse-inducing activities in the chick retinotectal system. 1 This molecule was later purified and cloned from the posterior part of the chick tectum. 2 RGM contains a putative autoproteolytic or an unstable cleavage site, and the cleaved mature protein has a molecular mass of 33 kDa. 3, 4 Recently, neogenin was identified as an RGM receptor; 5 this protein was originally isolated from embryonic chicken cerebellum as a deleted in colorectal cancer (DCC) homologue. 6 During central nervous system (CNS) development, neogenin mediates axon guidance by binding either RGM or netrin-1 7 and controls neuronal differentiation and survival. 8, 9 In the ligand-free state, neogenin induces apoptosis; 10 therefore, it belongs to the structurally unrelated, functionally defined family of 'dependence receptors'. This indicates that the absence of a ligand induces self-activation of the receptor with its subsequent proteolytic processing, thereby triggering apoptotic cell death. 11, 12 Neogenin overexpression or RGMa downregulation at E1.5 in the area of the developing chick neural tube resulted in an increase in the number of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)-positive cells. 10 However, the signal transduction mechanism that induces cell death is completely unknown and remains to be analyzed.
When attempting to elucidate the function of RGM and neogenin, we identified the serine/threonine kinase deathassociated protein kinase (DAPK) to be an interactor of neogenin. DAPK is a crucial intracellular protein that mediates cell death by its serine threonine kinase activity. [13] [14] [15] [16] DAPK has a multidomain structure that comprises a kinase domain, a calmodulin (CaM)-binding motif, eight ankyrin repeats, a cytoskeleton-binding region, and a death domain; the kinase and death domains are both important for the proapoptotic activity.
14,17 DAPK-mediated apoptosis is induced by a variety of stimuli such as interferon-g, TNF-a, TGF-b, ceramide, and the oncogenes c-myc and E2F. In this study, we provide evidence that DAPK is required for the proapoptotic activity of neogenin in vitro and in vivo.
Results
The ICD of neogenin interacts with DAPK. We first examined whether neogenin interacts with DAPK. Human embryonic kidney (HEK) 293 cells endogenously express DAPK (Figure 1a) , as previously reported, 4 and these cells were used for coimmunoprecipitation experiments. The fulllength neogenin was transfected into HEK293 cells. In the DAPK immunoprecipitates, an anti-neogenin antibody revealed of neogenin ( Figure 1a ). To test whether the interaction depends on ligand binding, we treated the cells with soluble RGMa and found that the interaction reduced due to RGMa treatment. However, treatment with soluble netrin-1 did not reduce the interaction (Figures 1a and b) . Further, the neogenin/DAPK interaction was not modified if DCC was present (Figure 1c) . DAPK was coimmunoprecipitated with neogenin when the antineogenin antibody was used for pull down (Figure 1d ). Reduced association was observed in the RGMa-treated cells, as in the case mentioned above. Other kinases (DCC) . At 48 h after the transfection, the cells were treated with or without soluble RGMa (1 mg/ml) or soluble netrin-1 (1 mg/ml) for 30 min. Immunoprecipitation of DAPK followed by western blot with the anti-neogenin antibody (upper panel), the anti-DCC antibody (the second panel), or the anti-DAPK antibody (the third panel). Representative pictures from three independent experiments show that neogenin, but not DCC, was coimmunoprecipitated with DAPK. Treatment of the cells with RGMa (1 mg/ml) decreased the binding, whereas netrin-1 (1 mg/ml) had no effect. The bottom panels show tubulin staining. The panels on the right side represent expression of the corresponding proteins in the lysates. (b) The neogenin/DAPK interaction was not changed by netrin-1. (c) The neogenin/DAPK interaction was not changed if DCC was present. (d) Immunoprecipitation of neogenin followed by western blot with the anti-DAPK antibody, the anti-Rho-kinase (ROCK) antibody, the anti-JNK antibody, the anti-p38a antibody, or the anti-neogenin antibody (neogenin). Representative pictures from three independent experiments show that association of DAPK with neogenin was observed in the absence of RGMa, whereas the binding was decreased by the RGMa treatment (1 mg/ml). The panels on the right side represent expression of the corresponding proteins in the lysates. (e) Immunoprecipitation of DCC followed by western blot with the anti-DAPK antibody. No signal for DAPK was observed including Rho-kinase, JNK, or p38 were not coimmunoprecipitated with neogenin ( Figure 1d ). In addition, we observed no signal for the interaction of DAPK and DCC (Figures 1a and e ). These results demonstrate that ectopically expressed neogenin constitutively associates with endogenous DAPK and that RGM binding to neogenin abolishes this interaction.
We then examined the interaction of these molecules by using lysates prepared from cerebellar granule neurons (CGNs), which express both proteins endogenously, from postnatal day (P) 7-8. DAPK was coimmunoprecipitated with neogenin, but was not coimmunoprecipitated when the cells were treated with RGMa or when DCC was immunoprecipitated ( Figure 2a) . Neogenin was coimunoprecipitated with DAPK if DAPK was immunoprecipitated with the antibody against DAPK (Figure 2a) . Next, we decided to perform immunodepletion of DAPK and neogenin to examine interaction of these molecules in CGNs. If DAPK binds to neogenin constitutively, the amount of free DAPK in the lysates should be reduced by the neogenin immunodepletion. Immunodepletion was performed using an antibody against neogenin, followed by western blot for DAPK (Figure 2b ; left). The result shows that the amount of DAPK in the supernatant was reduced after immunodepletion of neogenin, whereas the prior RGMa treatment significantly increased it. The amount of neogenin decreased after immunodepletion of DAPK (Figure 2b ; right). These data demonstrate that neogenin constitutively interacts with DAPK in rat CGNs. Moreover, RGMa appears to regulate the neogenin/DAPK interaction.
We further assessed interaction of these molecules by using lysates prepared from the mesencephalon from Hamburger Hamilton (HH) stage 17 chick embryos. Consistent with the observations in the CGNs, neogenin was coimmunoprecipitated with DAPK ( Figure 2c ).
To assess direct interaction of these two molecules, we employed the yeast two-hybrid system. The yeast reporter strain AH109 was cotransformed with a bait comprising the full intracellular domain (ICD) of neogenin fused to the GAL4 DNA-BD (pGBKT7-neogenin ICD) and a prey comprising DAPK fused to the GAL4 AD (pGADT7-DAPK). Strong growth of the yeast was detected only when both constructs were transformed (data not shown), demonstrating that neogenin ICD interacts with DAPK. Then, several deletion mutants of DAPK fused to the GAL4 AD (pGADT7-DAPK 1-275, 276-637, 638-847, 848-1129, 989-1270, and 1271-1423) were used to define the domains of DAPK that are necessary for the interaction. No growth was observed on adenine, histidine, tryptophan, and leucine-deficient medium in transformants of the neogenin ICD bait with DAPK 1-275, 276-637, 638-847, or 848-1129, whereas strong growth was detected with DAPK 989-1270 and 1271-1423 (Figure 3a) . Figure 2 Neogenin interacts with death-associated protein kinase (DAPK) in rat cerebellar granule neurons (CGNs) and chick brain. (a) Lysates from rat CGNs were immunoprecipitated with control IgG (control), anti-neogenin (IP: neogenin), anti-DAPK (IP: DAPK), or anti-deleted in colorectal cancer (DCC) antibody (IP: DCC). Representative pictures from three independent experiments are shown. DAPK was coimmunoprecipitated with neogenin, but was not coimmunoprecipitated when the cells were treated with RGMa (1 mg/ml). DAPK was not coimmunoprecipitated with DCC. (b) Lysates from rat CGNs were immunodepleted with the anti-neogenin (neogenin; left) or the anti-DAPK (DAPK; right). Representative pictures from three independent experiments are shown. The amount of DAPK in the supernatant (upper) was reduced after immunodepletion of neogenin (lower), whereas that the RGMa (1 mg/ml) treatment significantly increased it. Consistent with this observation, the amount of neogenin decreased when DAPK was immunodepleted. (c) Coimmunoprecipitation of neogenin with DAPK from lysates prepared from the mesencephalon from Hamburger Hamilton (HH) stage 17 chick embryos. Immunoprecipitation was performed using an antibody against DAPK, followed by western blot for neogenin domain or DAPK 989-1270 is sufficient for the interaction with neogenin.
We then tried to define the domains of neogenin that are necessary for the interaction with the death domain of DAPK. The ICD of neogenin has P1, P2, and P3 domains that are functionally important. 18 Various deletion constructs of neogenin ICD were used as shown in Figure 3b . The results demonstrate that both P2 and P3 domains were necessary for the interaction with the death domain of DAPK (Figure 3b) .
We further assessed direct interaction of DAPK with neogenin ICD using recombinant proteins. Three deletion mutants of His-tagged DAPK (848-1129, 989-1270, and 1271-1423; Figure 3c left panel) and GST-fused neogenin ICD were purified and used for pull-down assays. The death domain of DAPK was coprecipitated with GST-fused ICD of neogenin (Figure 3c ). However, we could not detect interaction of neogenin ICD with DAPK 989-1270 or DAPK 848-1129 (Figure 3c ).
RGM and neogenin regulate the activity of DAPK. DAPK is autophosphorylated on Ser308, which is located in the CaM-binding domain; this process disables the kinase activity. 17, 19 After demonstrating that neogenin interacts with DAPK, we proceeded to investigate the effects of neogenin on DAPK phosphorylation. To analyze whether DAPK phosphorylation is regulated by neogenin, HEK293 cells were transiently cotransfected with a control or a VSV-G-tagged neogenin construct together with an HA-tagged wild-type DAPK construct. Autophosphorylation of DAPK was examined in the presence or absence of soluble RGMa by using immunodetection on western blots with a (Figure 4a ), whereas the presence of RGMa completely restored DAPK autophosphorylation ( Figure 4a ). Next, we performed kinase assays to assess the activity of DAPK using myosin light chain (MLC) as a substrate. The HEK293 cells were transfected with wild-type DAPK and VSV-G-tagged neogenin, and were treated with soluble RGMa. Transfected DAPK was immunoprecipitated from the cell lysates, and the phosphorylation of MLC by the immunoprecipitated DAPK was measured. Overexpression of neogenin resulted in enhancement of the activity of DAPK, whereas the RGMa treatment reduced the activity (Figure 4b ). We further assessed this issue by employing the CGNs that express neogenin and DAPK endogenously. Autophosphorylation of DAPK was examined in the presence or absence of soluble RGMa. The presence of RGMa enhanced DAPK autophosphorylation (Figure 4c) . Thus, the ligand-receptor pair RGMa/neogenin regulates autophosphorylation and the activation of DAPK.
Neogenin proapoptotic activity is mediated by DAPK in HEK293 cells. The above-mentioned results suggest importance of DAPK in neogenin-mediated cell death. We further examined whether full-length neogenin displays a proapoptotic activity in HEK293 cells. To address this, TUNEL staining was performed 48 h after transfection in combination with staining with an anti-VSV-G antibody and 4 0 ,6 0 -diamidino-2-phenylindole (DAPI). The number of TUNEL-positive cells was significantly increased in HEK293 cells that were transfected with the full-length neogenin construct, whereas the addition of RGMa inhibited the proapoptotic effect of neogenin (Figures 5a-e) . Approximately 40% of the cells were TUNEL positive by the neogenin overexpression ( Figure 5d ). We subsequently analyzed whether the inhibition of endogenous DAPK activity possibly modulates neogenin-mediated cell death. A kinasedead mutant (K42A) was used as a dominant-negative form . We further assessed involvement of DAPK using the RNA interference technique. The HEK293 cells or rat CGNs were transfected with DAPK small-interference RNA (siRNA) or the control siRNA, and the expression of DAPK was determined by western blot analysis (Figures 5f  and 6a ). The result demonstrated that DAPK expression was decreased specifically after the DAPK siRNA transfection in HEK293 cells as well as rat CGNs. The neogenin-mediated increase in the number of TUNEL-positive cells was completely inhibited when DAPK siRNA was transfected (Figures 5g and h, Supplementary Figure 1 ), These results demonstrate that neogenin proapoptotic activity is mediated by DAPK in HEK293 cells.
To ask if absence of RGMa is associated with an increase in death of the CGNs, the CGNs were stained for TUNEL in the presence or absence of RGMa (Figure 6b ). The cell death was not induced in the absence of RGMa. Knockdown of DAPK by siRNA (Figure 6a ) did not influence the number of TUNELpositive cells (Figures 6b and c) . These results suggest that cell death induction by neogenin is cell-type specific, or that neogenin-expression level was not high enough to induce cell death. We further assessed the importance of DAPK in the CGNs. Although addition of RGMa induces growth cone collapse of the CGNs, knockdown of DAPK by siRNA did not modulate the effect of RGMa (Figures 6d and e) . Therefore, DAPK appears not to be involved in the RGM-mediated growth cone collapse.
Cytochrome c release from the mitochondria induced by neogenin is dependent on DAPK. The release of cytochrome c into the cytosol is an early step in apoptotic cell death. 21 In this regard, we examined whether neogenin could induce the release of cytochrome c in HEK293 cells. Immunofluorescence staining of HEK293 cells with an anticytochrome c antibody yielded a punctate pattern, which is characteristic of mitochondrial localization (Figure 7a ; control). However, diffuse cytochrome c staining was observed in the case of cells transfected with the full-length neogenin construct (Figure 7a Cell death induced by neogenin is dependent on DAPK in the chick neural tube. To test whether DAPK is involved in neogenin-mediated cell death in vivo, we analyzed cell death in neural tubes of chick embryos. We performed immunohistochemistry to investigate the distribution of DAPK in the chick neural tube. Cryostat sections at the level of the mesencephalon from HH stage 17 embryos were used for immunostaining. A strong immunoreactivity for RGM as well as DAPK was found in the neural tube (Figures 8a and b) . These immunohistochemical observations were confirmed by western blotting using lysates from the neural tube tissues (Figure 8c ). We electroporated a green fluorescent protein (GFP) expression construct into a chick neural tube (HH stage 10). The electroporated area, which expressed GFP, covered the dorsal metencephalon, mesencephalon, and caudal diencephalons (Figure 8d) . At 24 h after the electroporation, chick embryos were fixed and TUNEL staining was subsequently performed (Figure 8e ). No significant increase in the number of TUNEL-positive cells Using this in vivo system, we then assessed whether the proapoptotic activity of neogenin in vivo is dependent on the DAPK activity. We electroporated the control or VSV-Gtagged neogenin constructs in combination with or without DAPK-d/n together with the GFP-expression construct in HH stage 10 chick embryos. The signals for GFP (green), DAPKd/n (red), and neogenin (blue) were observed in the electroporated side after coelectroporation of the constructs (Figures 9a and b) . TUNEL staining was performed 24 h after electroporation. There was an increase in the number of TUNEL-positive cells on the experimental side after neogenin electroporation (Figures 9c-e) . Coelectroporation of DAPK-d/n and VSV-G-tagged neogenin resulted in the disappearance of the TUNEL-positive cells. We obtained consistent results when DAP siRNA was electroporated (Figure 9e and Supplementary Figure 3) . We then electroporated the control or VSV-G-tagged neogenin deletion constructs (neogenin ICD, neogenin ICD (1127-1323), and neogenin ICD (1324-1461)) in combination with or without DAPK-d/n. Our yeast two-hybrid data show that P2 and P3 domains of neogenin were necessary for binding with the death domain of DAPK. Although neogenin ICD (1127-1323) contains only P1 domain, neogenin ICD (1324-1461) contains both P2 and P3 domains. As electroporation of either construct did not increase the number of the TUNEL-positive cells (Figure 9f) , the N-terminal domain of neogenin ICD may also be necessary for inducing cell death.
There was an increase in the number of TUNEL-positive cells on the experimental side after wild-type DAPK electroporation (Figures 9g and h) . When neogenin and DAPK-d/n were simultaneously coelectroporated, there was no reduction in the expression of VSV-G-tagged neogenin as compared to VSV-G-tagged neogenin single electroporation (Figures 9i and j) . This excludes the possibility that reduction of neogenin-induced apoptosis was due to the reduced expression of neogenin. In addition, DAPK-d/n or DAPK siRNA did not influence the number of the TUNEL-positive cells by itself (Figures 9c-e ). These data demonstrate that the The effects of RGM silencing are mediated by DAPK. RGM expression was repressed using siRNA construct for RGM (RGM siRNA). Electroporation of the RGM siRNA construct into the neural tube indeed repressed the endogenous RGM expression (Figure 10a) . Further, immunostaining for GAPDH, DAPK, or neogenin in combination with GFP fluorescence in the neural tube 24 h after coelectroporation of corresponding siRNA demonstrates that expression of the corresponding protein was repressed in the area where GFP was expressed ( Figure  10b ). Thus, GFP is a good marker for the siRNA expression. Figure 10c shows the immunostaining for RGM and DAPK-d/n. The signals for GFP (green) and DAPK-d/n (blue) were colocalized in the electroporated side after coelectroporation. Expression of RGM (red) was reduced in the area where GFP (green) as well as DAPK-d/n (blue) was expressed in the neural tube (Figure 10c ). The TUNEL staining demonstrated that the electroporation of the RGM siRNA, but not GAPDH siRNA, induced apoptosis on the experimental side ( Figures  10d and e) . This confirms that RGM functions as a cell survival factor to counteract neogenin proapoptotic activity. We then examined whether DAPK is associated with the apoptosisinducing effect of RGM silencing. Coelectroporation of the RGM siRNA and DAPK-d/n was performed in the neural tube (Figures 10d and e) . The number of the TUNEL-positive cells on the experimental side 24 h after the coelectroporation of RGM siRNA and DAPK-d/n was significantly decreased as compared to that after single electroporation of the RGM siRNA construct (Figures 10d and e) . Consistent with this, coelectroporation of DAPK siRNA also reduced the number of the TUNEL-positive cells induced by RGM siRNA (Figures 10d  and e) . Coelectroporation of neogenin siRNA reduced the number of the TUNEL-positive cells induced by RGM siRNA (Figures 10d and e) , supporting the notion that the effect of RGM silencing is mediated by neogenin. These data demonstrate that the cell death is induced in the absence of RGM in the chick neural tube and that the DAPK activity is required for this effect.
Discussion
To date, various receptors have been identified as dependence receptors, including DCC, p75 neurotrophin receptor, patched, the UNC-5 homologue, integrin receptors (a v b 3 , a 5 b 1 ), and the androgen receptor. 3 A comparison of human neogenin and human DCC has revealed that both proteins have identical domain structures and share 50% amino-acid identity. A high degree of similarity exists between the fourth fibronectin III and the fourth immunoglobulin domain of the extracellular portion. However, the cytoplasmic domains of both proteins are less conserved, with only 37% identity at the amino-acid level. A considerably higher amino-acid identity (97%) is observed in the P3 domain of the ICDs of neogenin and DCC, a region shown to be responsible for focal adhesion kinase (FAK) binding to both proteins. 22, 23 Excluding this small homologous region, the ICD of neogenin shows no similarity with any other protein in the database. Thus, it was suggested that neogenin exerts its proapoptotic activity by using a molecular pathway distinct from DCC or other dependence receptors.
The RGM-neogenin interaction has diverse functions in the developing CNS. In Xenopus embryos, downregulation of RGMa, netrin-1, or neogenin by a morpholino antisense strategy lead to aberrant projections of the supraoptic tract in the forebrain. The aberrant projection phenotype of the RGMa knockdown was very similar in extent and morphology to the neogenin knockdown. 7 Interestingly, recent report demonstrated that RGM was expressed in the developing retina. 24 Abnormal topographic targeting of retinotectal projection was found when RGM expression in the retinal ganglion cells was perturbed, suggesting that RGM in the axons is also important in axon guidance. In addition, we observed an unexpected importance of RGMa in early embryonic development when analyzing the RGMa knockout mice. These mice show deficits in neural tube closure at the cephalic level, resulting in an exencephalic phenotype with major morphological defects of the dorsal brain structures. 25 In the adult CNS, reexpression of RGM is observed following injury and ischemic stroke in the adult human CNS and after a spinal cord injury in rats. 26, 27 Recently, we reported that the inhibition of RGMa enhances the growth of injured axons and promotes functional recovery after spinal cord injury in rats. 28 Therefore, an interesting hypothesis is that DAPK may kill the neurons after injury or ischemic damage in the CNS but RGM possibly suppresses the DAPK proapoptotic effect as well as axon regeneration. It will be interesting to assess whether DAPK is important in the final cell-fate decision in the pathological state in adults as well as in the developmental stages.
In addition to the importance in inducing cell death, DAPK was recently shown to have apoptosis-independent effects on the cytoskeletons; 29 it also inhibits integrin activity. 16 DAPK associates with the stress fibers to induce the inhibition of integrins by the cytoskeletal-binding domain of DAPK. 30 However, DAPK is not associated with growth cone collapse induced by RGM in our experimental conditions. The association of DAPK with stress fibers hints at its possible interaction with the RhoA/Rho-kinase pathway. Activation of the RhoA/Rho-kinase pathway is a key signal for axon growth inhibition in the CNS. 31 Indeed, RGM activates RhoA and Rho-kinase and inhibits neurite growth of the CGNs in vitro by activating RhoA. 28 A possible cross talk between Rho-kinase and DAPK downstream of RGM-neogenin is suggested in that they share the same substrate myosin-regulatory light chain;
32 such interactions should be tested in the future. 0 -GTGGTG GCCATCAATGATC-3 0 was used. To drive siRNA expression in the neural tube, the target cDNAs were inserted in the pSilencer1.0-U6 vector (Ambion, Huntingdon, Cambridgeshire, UK). The wild-type DAPK and the DAPK-d/n in pcDNA3.1 were gifts from Dr. Adi Kimchi.
Cell cultures and transfection. For CGNs, the cerebella of P7-8 rats were removed and mixed with 0.25% trypsin, triturated, and incubated with 200 U/ml DNase1 (Takara, Shiga, Japan) for 15 min at 371C. Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS) was added, and the cells were centrifuged at 1000 r.p.m. for 5 min. Neurons were plated on poly-L-lysine-coated chamber slides and were maintained in DMEM/ F12 containing 10% FBS at 371C in 5% CO 2 . CGNs (5 Â 10 6 ) were suspended in 100 ml of Nucleofector solution (Amaxa Biosystems, Cologne, Germany) containing 500 pmol of siRNA. Electroporation was performed by using program O-003 as described by the manufacturer's protocol (Amaxa Biosystems). Transient transfection of HEK293 cells was performed using Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen). Immunoprecipitation, DAPK phosphorylation assays, and the TUNEL assays were performed 48 h after transfection.
Coimmunoprecipitation. HEK293 cells were lysed in lysis buffer containing 20 mM Hepes (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS and a protease inhibitor mixture (Roche Diagnostics K.K., Tokyo, Japan). The lysates were centrifuged at 20 000 Â g at 41C for 15 min, and the supernatants were collected. The clear lysates obtained from HEK293 cells were incubated overnight at 41C with the anti-DAPK antibody or the anti-neogenin antibody to pull down endogenous DAPK or neogenin, respectively. The anti-HA antibody or the anti-VSV-G antibody was used to pull down HA-tagged DAPK or VSV-G-tagged neogenin, respectively. Rat CGNs were lysed in lysis buffer containing 50 mM TrisHCl (pH 7.5), 150 mM NaCl, 10% glycerol, 0.5% Brij-58 (Sigma-Aldrich Inc.), and a protease inhibitor mixture (Roche Diagnostics K.K.). The lysates were centrifuged at 20 000 Â g at 41C for 10 min, and the supernatants were collected and incubated with either the anti-DAPK antibody or the anti-neogenin antibody to pull down endogenous DAPK or neogenin, respectively. Chick Brains were homogenized in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, and a protease inhibitor mixture (Roche Diagnostics K.K.). The lysates were centrifuged at 20 000 Â g at 41C for 15 min, and the supernatants were collected and incubated with either the anti-DAPK antibody or the anti-neogenin antibody to pull down endogenous DAPK or neogenin, respectively. The immunocomplex was collected using Protein G Sepharose beads (Amersham Biosciences, Piscataway, NJ, USA). The beads were washed 4 Â with the lysis buffer. The bound proteins were eluted with 2 Â Laemmli sample buffer and subjected to SDS-PAGE followed by immunoblot analysis. The anti-VSV-G antibody or the anti-neogenin antibody was used for detecting neogenin, and the anti-HA antibody or the anti-DAPK antibody was used for DAPK detection. Where indicated, the cells were treated with recombinant mouse RGMa (1 mg/ml, R&D Systems) or recombinant mouse netrin-1 (1 mg/ml, R&D Systems).
Immunodepletion. For immunodepletion, anti-neogenin antibody, or anti-DAPK antibody was coupled to Protein G Sepharose beads (Amersham Biosciences), respectively. Rat CGNs were lysed in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10% glycerol, 0.5% Brij-58 (Sigma-Aldrich Inc.), and a protease inhibitor mixture (Roche Diagnostics K.K.). The lysates were centrifuged at 20 000 Â g at 41C for 10 min, and the supernatants were collected and incubated overnight at 41C with the antibody beads. The mixture was centrifuged at 8000 Â g at 41C for 10 min to remove the precipitate and the supernatant was used as immunodepleted conditions in western blot analysis. were subcloned into the pGBKT7 and pGADT7 vectors, respectively, and the oneon-one transformation assays were performed. The yeast reporter strain AH109 was transformed by the lithium acetate method, and positive clones were selected on plates lacking adenine, histidine, tryptophan, and leucine.
Protein purification and pull-down assay. The DNA fragment encoding the neogenin ICD was cloned to pGEX-6P-3 (GE Healthcare Ltd., UK) vector. His-tagged various fragments of DAPK were cloned to pET-29a( þ ) vector. Production and purification of the His-tagged proteins were prepared according to the manufacturer's instructions (Novagen). For pull-down assay, equal amounts of GST fusion proteins immobilized on beads were incubated at 41C for 2 h with Histagged DAPK proteins in GST-binding buffer (50 mM Hepes (pH 7.5), 1% NP-40, 50 mM NaCl, 10 mM EDTA, 20% glycerol, 1 mM PMSF, 1 mg/ml aprotinin, and 1 mg/ ml leupeptin). The beads were washed, and proteins bound on beads were analyzed by western blot.
Western blotting. For assessing the phosphorylation state of DAPK, the cells were lysed in lysis buffer containing 50 mM Tris-HCl (pH7.4), 150 mM NaCl, 1% NP-40, 2 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate, and the protease inhibitor mixture. For chick embryo experiments, the neural tubes from HH 17 embryos were dissected and triturated. They were then incubated in the lysis buffer described above, followed by sonication. These lysates were purified by centrifugation at 20 000 Â g at 41C for 15 min, and the supernatants were collected and normalized for protein concentration. Equal amounts of proteins were then boiled in sample buffer for 5 min and were subjected to SDS-PAGE. The proteins were transferred onto a membrane and incubated with primary antibodies. For detection, the ECL chemiluminescence system (GE Healthcare, Piscataway, NJ, USA) and secondary antibodies were used.
Kinase assay. HEK293 cells were lysed in RIPA buffer supplemented with 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml aprotinin leupeptin, 1 mM sodium orthovanadate, 4 mM sodium pyrophosphate, and 20 mM NaF. DAPK immunoprecipitated by anti-HA-tagged antibody was incubated with MLC kinase buffer (50 mM Hepes (pH 7.5), 8 mM MgCl 2 , 2 mM MnCl 2 , 0.5 mM CaCl 2 , 50 mM ATP, 0.1 mg/ml bovine serum albumin (BSA), 1 mM CaM (Sigma-Aldrich Inc.)) at 251C for 10 min. The kinase reactions were resolved by SDS-PAGE, and MLC phosphorylation was detected by immunoblot. The same kinase reactions were subjected to immunoblot analysis to detect the precipitated HA-DAPK. Immunoblot data were quantified by measuring the band intensity (background intensity corresponding to MLC phosphorylation without DAPK was subtracted) using Scion Image software (Scion Corporation, ML, USA).
Immunocytochemistry and immunohistochemistry. Transfected HEK293 cells were fixed for 2 h or overnight at 41C by using 4% paraformaldehyde (PFA). Chick embryos were fixed for 30 min with 4% PFA, 0.2% glutaraldehyde, and 0.02% NP-40. For chick tissues, 20-mm thick sections were made using a cryostat. The sections or the fixed cells were blocked with PBS containing 10% BSA and 0.1% Triton X-100 for 2 h at room temperature and were incubated with the appropriate antibodies in PBS containing 5% BSA. Immunoreactivity was visualized using fluorescence-conjugated secondary antibodies or biotinylated secondary antibodies in combination with ABC system (Vector). Coverslips were then mounted with a mounting medium after DAPI staining for fluorescent staining.
TUNEL and cytochrome c release assay. The TUNEL assay was performed using the ApopTag in situ apoptosis detection kit (Chemicon, Tamecula, CA, USA) according to the manufacturer's instructions. The index factor in the in vitro assays is the relative number of TUNEL-positive cells as compared with the control. The index factor in the in ovo electroporation experiments is the ratio between the number of TUNEL-positive cells on the electroporated side and that on the control side (equal squares were selected for measurement, as indicated in Figure 7d) . A minimum of four embryos and three sections per embryo were counted for each experimental condition. For the cytochrome c release assay, the transfected HEK293 cells were immunostained with the anti-cytochrome c antibody. Quantification was performed by measuring the number of the cells with diffuse cytochrome c staining patterns among all the cells or the cells expressing VSV-G neogenin. For cell fractionation analysis, cytosolic and mitochondrial proteins were isolated using a commercially available mitochondria/cytosol fractionation kit (BioVision). Cells were collected by centrifugation at 600 Â g for 5 min and resuspended in kit-provided cytosol extraction buffer containing protease inhibitor mixture and dithiothreitol. After incubation on ice for 10 min, the cells were homogenized on ice. Homogenizations were centrifuged at 700 Â g for 10 min at 41C, and the supernatants were collected. Then, the collected supernatants were centrifuged again at 10 000 Â g for 30 min at 41C. The resulting supernatants were designated as cytosolic fractions, and the pellets were resuspended in kit-provided mitochondria extraction buffer and designated as mitochondrial fractions. Protein content was determined using BCA protein assay kit (Pierce, Rockford, IL, USA). Equivalent amounts of mitochondrial and cytosolic proteins were separated on SDS-PAGE and transferred onto membranes. Then, western blot analysis was performed. b-actin (cytosol) and VDAC1 (mitochondria) served as loading normalization.
In ovo electroporation. Fertilized chicken eggs were obtained from a local farm and were incubated at 381C. Various constructs in the solution were injected into HH stage 10 chick embryos by in ovo electroporation. These included human VSV-G-tagged full-length neogenin in pcDNA3.1 (1.0 mg/ml), siRNA plasmids (1.0 mg/ml), DAPK wild type in pcDNA3.1 (1.0 mg/ml), and DAPK-d/n in pcDNA3.1 (1.3 mg/ml). Electroporation was performed using a CUY21 electroporator and a CUY-610 standard electrode (NEPA gene, Chiba, Japan). We carried out electroporation by using five pulses of 50-ms duration at 25 V. The GFPexpression vector (pcDNA3.1, 0.5 mg/ml) was coelectroporated to assess the electroporation efficiency. At 24 h later, the embryos were fixed and then subjected to the TUNEL assay and immunohistochemistry.
Growth cone collapse assay. CGNs were transfected with control siRNA or DAPK siRNA by using nucleofection. After 48 h culture, cells were treated with or without soluble RGMa (2 mg/ml) for 30 min. Then, the cells were fixed with 0.5% glutaraldehyde for 1 h at room temperature, and treated with PBS containing 5% BSA and 0.1% Triton X-100. The cells were incubated with anti-Tuj1 antibody and rhodamine-phalloidin for 2 h at room temperature, followed by incubation with antimouse IgG antibody conjugated with Alexa Fluor 568 (Invitrogen) for 1 h at room temperature. Finally, they were analyzed using Olympus BX51 microscopy.
